VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 355 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2013. The put-call ratio across all filers is 0.61 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $73,000 | +9.0% | 3,162 | -4.3% | 0.00% | – |
Q1 2018 | $67,000 | 0.0% | 3,305 | 0.0% | 0.00% | – |
Q4 2017 | $67,000 | +39.6% | 3,305 | -4.6% | 0.00% | – |
Q3 2017 | $48,000 | +9.1% | 3,466 | -14.9% | 0.00% | – |
Q2 2017 | $44,000 | 0.0% | 4,075 | 0.0% | 0.00% | – |
Q1 2017 | $44,000 | -12.0% | 4,075 | +16.6% | 0.00% | – |
Q4 2016 | $50,000 | -43.2% | 3,495 | -3.4% | 0.00% | – |
Q3 2016 | $88,000 | +23.9% | 3,619 | +0.9% | 0.00% | – |
Q2 2016 | $71,000 | +36.5% | 3,585 | +80.0% | 0.00% | – |
Q1 2016 | $52,000 | -79.3% | 1,992 | -19.4% | 0.00% | -100.0% |
Q4 2015 | $251,000 | -49.0% | 2,472 | -10.4% | 0.00% | -50.0% |
Q3 2015 | $492,000 | -17.9% | 2,759 | +2.0% | 0.00% | 0.0% |
Q2 2015 | $599,000 | +37.4% | 2,704 | +22.9% | 0.00% | +33.3% |
Q1 2015 | $436,000 | +55.2% | 2,200 | +11.6% | 0.00% | +50.0% |
Q4 2014 | $281,000 | -10.8% | 1,971 | -18.3% | 0.00% | -33.3% |
Q3 2014 | $315,000 | -26.2% | 2,412 | -29.0% | 0.00% | -25.0% |
Q2 2014 | $427,000 | +7.0% | 3,395 | +12.0% | 0.00% | 0.0% |
Q1 2014 | $399,000 | -5.5% | 3,030 | -15.9% | 0.00% | 0.0% |
Q4 2013 | $422,000 | -45.5% | 3,604 | -51.5% | 0.00% | -55.6% |
Q3 2013 | $774,000 | +27.1% | 7,429 | +4.9% | 0.01% | +12.5% |
Q2 2013 | $609,000 | – | 7,084 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |